MEPC, developer of Milton Park near Didcot, has announced that 142 and 143 Park Drive have reached completion, concluding the construction phase of the £24m development.

The three-storey building at 142 Park Drive offers 41,000 sq ft of high-quality laboratory and hi-tech office space, with two floors left open to provide flexible fit-out options.

Offices have been designed to encourage expansion among innovative occupiers in the science and technology sector.

At 27,000 sq ft, 143 Park Drive is already pre-let to Oxford Immunotec, a NASDAQ listed Oxford University spin-out which has expanded from an existing premises at the park, where it has been located for over 10 years.

The move combines two out of three existing Oxford Immunotec facilities at Milton Park into a brand new, purpose-built facility, which will house manufacturing rooms, R&D laboratories, the company’s clinical laboratory as well as sales, marketing and various headquarters functions.

The news follows the completion of 141 Park Drive in February which, at 42,000 sq ft, is one of the region’s largest office and laboratory buildings.

Philip Campbell, commercial director for MEPC at Milton Park said: “This a fantastic milestone and we are proud to announce that Park Drive East is now complete.

“Our priority at Milton Park is to create an attractive environment where innovative businesses can thrive and expand, as well as driving job creation and help to bolster the local economy.

“In recent years, Milton Park has seen almost full occupancy.”

For more visit